US home sales rebound slightly in February U.S. home sales picked up slightly in February but remain sluggish due to tight inventories, affordability problems and nasty winter weather. More
US home building is surging, but job growth isn't The resurgent U.S. housing market has sent builders calling again for Richard Vap, who owns a drywall installation company. Vap would love to help - if he could hire enough qualified people. "There is a shortage of manpower," says Vap, owner of South Valley Drywall in Littleton, Colo. More
HTC Expects Brighter Second Quarter Taiwan's HTC expects its second-quarter revenue and operating margin to rise from the first quarter, as sales of the new HTC One smartphone pick up. More
Mobile Efforts Help Propel Facebook’s Earnings Facebook was once a darling of investors, then a turnoff. Now, a year after going public, the social network seems to have settled into a more stable relationship with Wall Street. But the company has still been taking pains to prove that it can make more money from its base of more than a billion users, especially from those using Facebook on mobile devices. More
TNW has strengthened its support for European tech by adding ecosystems expert Yeni Joseph to the management team. Yeni has also started a new role as Head of Ecosystem Strategy and Partnerships. The appointment brings extensive expertise to TNW’s leadership — and fresh ideas. “TNW has a long-standing track record of catalysing innovation,” says Yeni.
London-headquartered biotech startup Verdiva has emerged from stealth with a whopping $410mn for a new range of drugs aimed at tackling the obesity epidemic. It’s one of Europe’s largest-ever biotech VC deals, signalling investor appetite for the booming weight loss market. Verdiva looks to challenge the dominance of Novo Nordisk and Eli Lilly, the makers of the two most popular weight loss drugs, Ozempic and Wegovy.